ISRCTN44202629已完成不适用
Genotype and response to treatment for age related macular degeneration (ARMD): a multicentre, non-randomised, interventional, cohort study
eeds Teaching Hospitals NHS Trust (UK)0 个研究点目标入组 350 人开始时间: 2010年5月28日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged over 65 years, either sex
- •2. Affected with ARM
- •3. Currently under treatment with ranibizumab (Lucentis)
- •4. Patients with lesions of greatest linear diameter less than 5400 microns
排除标准
- •1. Patients with poor general health
- •2. Patients with other eye pathology likely to affect response to treatment
- •3. Patients with lesions of greatest linear diameter greater than 5400 microns
- •4. Patients currently being treated with other anti-VEGF agents (systemic or ocular)
研究者
相似试验
进行中（未招募）
不适用
Do genes predict response to treatment in age-related macular degeneration? - ARMD pharmacogeneticsEUCTR2008-007319-33-GBeeds Teaching Hospitals NHS Trust
已完成
不适用
The evaluation of treatment effect for age-related macular degeneration by using aflibercept preferentially in Yamaguchi University.age-related macular degenerationJPRN-UMIN000038335Department of Ophthalmology Yamaguchi University graduate school of medicine73
已完成
不适用
Analysis of genotypes associated with the treatment effects of Lucentis for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000005584Kyoto University Graduate School of Medicine, Department of Ophthalmology and Visual Sciences600
已完成
Unknown
Genetic Markers of Response to Newer Therapies for Type 2 DiabetesE11Type 2 diabetes mellitusDRKS00034478Faculty of Medicine, University of Ljubljana161
已完成
不适用
GENetic and clinical Predictors Of treatment response in DepressioDepressionISRCTN31345163Medical Research Council (UK)887